Cost-effectiveness and value of information analysis of multiple frequency bioimpedance devices for fluid management in people with chronic kidney disease having dialysis
Jacobsen, E., Cruickshank, M., Cooper, D., Marks, A., Brazzelli, M., Scotland, G.
Cost Effectiveness and Resource Allocation, vol. 19, 24
Early constipation predicts faster dementia onset in Parkinson’s disease
Camacho, M., MacLeod, A., Maple-Grødem, J., Evans, J., Breen, D., Cummings, G., Wijeyekoon, R., Greenland, J., Alves, G., Tysnes, O., Lawson, R., Barker, R. A., Williams-Gray, C.
Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis: An Individual Participant–Based Meta-analysis
Sumida, K., Nadkarni, G. N., Grams, M. E., Sang, Y., Ballew, S. H., Coresh, J., Matsushita, K., Surapaneni, A., Brunskill, N., Chadban, S. J., Chang, A. R., Cirillo, M., Daratha, K. B., Gansevoort, R. T., Garg, A. X., Iacoviello, L., Kayama, T., Konta, T., Kovesdy, C. P., Lash, J., Lee, B. J., Major, R., Metzger, M., Miura, K., Naimark, D. M., Nelson, R. G., Sawhney, S., Stempniewicz, N., Tang, M., Townsend, R. R., Traynor, J. P., Valdivielso, J. M., Wetzels, J., Polkinghorne, K. R., Heerspink, H. J., Chronic Kidney Disease Prognosis Consortium
Annals of Internal Medicine, vol. 173, no. 6, pp. 426-435
Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson's disease
Ramsay, N., MacLeod, A. D., Alves, G., Camacho, M., Forsgren, L., Lawson, R. A., Maple-Grødem, J., Tysnes, O., Williams-Gray, C. H., Yarnall, A. J., Counsell, C. E., Parkinson’s Incidence Cohorts Collaboration
Parkinsonism & Related Disorders, vol. 76, pp. 49-53
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
Auguste, P., Colquitt, J., Connock, M., Loveman, E., Court, R., Ciccarelli, O., Counsell, C., Armoiry, X.
